Welcome to the official website of BioCoreUSA Corp!
  • Cores:
    96
    CASES:
    67
    Core Diameter(mm):
    1
    Thickness(µm):
    5
    Row number:
    8
    Column number:
    12
    Tissue Array Type:
    FFPE
    Species:
    Human
BCN962c
$255.00
Add To Collect

Description: Mutiple organ tumor with cancer adjacent or adjacent normal tissue array, including pathology grade, TNM and clinical stage, 67 cases/96 cores, replacing BCN962b

Details: Mutiple organ tumor with cancer adjacent or adjacent normal tissue microarray, containing 16 organs of tumor with matched or unmatched cancer adjacent or adjacent normal tissue (esophagus, stomach, colon, prostate, liver, lung, kindey, breast, cervix, ovary, bladder, lymph node, skin, pancreas, testis and tongue), plus 2 placenta tissue, single core per block

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • Malignant()
  • Malignant(0)
  • NAT()
  • Normal()
  • NAT(*)
  • AT(*)
  • Malignant(*)
  • Malignant(IB1)
  • Malignant(I)
  • Malignant(IA)
  • Malignant(IB)
  • Malignant(IIA)
  • Malignant(IIB)
  • Malignant(IIC)
  • Malignant(II)
  • Malignant(IIIA)
  • Malignant(IIIC)
  • Malignant(III)
  • _ma
TISSUE ARRAYS
BCN962c
1
2
3
4
5
6
7
8
9
10
11
12
A
Eso
Eso
Eso
Sto
Sto
Sto
Col
Col
Col
Pro
Pro
Pro
B
Eso
Eso
Eso
Sto
Sto
Sto
Col
Col
Col
Pro
Pro
Pro
C
Liv
Liv
Liv
Lun
Lun
Lun
Kin
Kin
Kin
Bre
Bre
Bre
D
Liv
Liv
Liv
Lun
Lun
Lun
Kin
Kin
Kin
Bre
Bre
Bre
E
Cer
Cer
Cer
Ova
Ova
Ova
Bla
Bla
Bla
Lym
Lym
Lym
F
Cer
Cer
Cer
Ova
Ova
Ova
Bla
Bla
Bla
Lym
Lym
Lym
G
Ski
Ski
Ski
Pan
Pan
Pan
Tes
Tes
Tes
Tes
Tes
Ton
H
Ski
Ski
Ski
Pan
Pan
Pan
Tes
Tes
Tes
Tes
Pla
Pla
_ma
BCN962c
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type
A1
1 58 F Esophagus Squamous cell carcinoma 1 T1bN0M0 I Malignant
A2
2 67 M Esophagus Squamous cell carcinoma 1 T3N0M0 II Malignant
A3
3 70 M Esophagus Squamous cell carcinoma 3 T3N1M0 III Malignant
A4
4 66 M Stomach Adenocarcinoma 3 T3N2M0 III Malignant
A5
5 53 M Stomach Adenocarcinoma 3 T3N2M0 III Malignant
A6
6 34 F Stomach Adenocarcinoma 3 T3N0M0 IIB Malignant
A7
7 70 F Colon Adenocarcinoma (sparse) 2 T3N0M0 IIA Malignant
A8
8 37 M Colon Adenocarcinoma 2 T3N0M0 IIA Malignant
A9
9 44 F Colon Mucinous adenocarcinoma 3 T3N0M0 IIA Malignant
A10
10 56 M Prostate Adenocarcinoma (Gleason grade: 4, Gleason score: 4+4) 3 T3N0M0 III Malignant
A11
11 64 M Prostate Adenocarcinoma (Gleason grade: 5, Gleason score: 5+5) 3 T2N0M0 II Malignant
A12
12 64 M Prostate Adenocarcinoma (Gleason grade: 5, Gleason score: 5+5) 3 T2bN0M0 II Malignant
B1
13 58 F Esophagus Adjacent normal esophagus tissue of No.1 * * * NAT
B2
14 67 M Esophagus Adjacent normal esophagus tissue of No.2 * * * NAT
B3
15 70 M Esophagus Adjacent normal esophagus tissue of No.3 * * * NAT
B4
16 66 M Stomach Adjacent normal stomach tissue of No.4 * * * NAT
B5
17 53 M Stomach Cancer adjacent stomach tissue of No.5 * * * AT
B6
18 34 F Stomach Adjacent normal stomach tissue of No.6 * * * NAT
B7
19 71 M Colon Adjacent normal colon tissue of No.7 * * * NAT
B8
20 37 M Colon Adjacent normal colon tissue of No.8 * * * NAT
B9
21 44 F Colon Cancer adjacent colon tissue of No.9 * * * AT
B10
22 66 M Prostate Cancer adjacent prostate tissue * * * AT
B11
23 71 M Prostate Cancer adjacent prostate tissue * * * AT
B12
24 64 M Prostate Cancer adjacent prostate tissue * * * AT
C1
25 48 F Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant
C2
26 52 F Liver Hepatocellular carcinoma 3 T2N0M0 II Malignant
C3
27 43 F Liver Hepatocellular carcinoma 3 T2N0M0 II Malignant
C4
28 59 M Lung Invasive adenocarcinoma * T2aN0M0 IB Malignant
C5
29 70 M Lung Squamous cell carcinoma 2 T3N0M0 IIB Malignant
C6
30 62 M Lung Squamous cell carcinoma 3 T2aN1M0 IIB Malignant
C7
31 72 F Kindey Clear cell carcinoma 1 T1bN0M0 I Malignant
C8
32 57 M Kindey Clear cell carcinoma 1 T1bN0M0 I Malignant
C9
33 45 F Kindey Clear cell carcinoma 1 T1N0M0 I Malignant
C10
34 53 F Breast Invasive carcinoma of no special type 2 T2N0M0 IIA Malignant
C11
35 49 F Breast Invasive carcinoma of no special type 2 * * Malignant
C12
36 29 F Breast Invasive carcinoma of no special type (breast tissue) * T2N0M0 IIA Malignant
D1
37 48 F Liver Cancer adjacent liver tissue of No.25 - * * AT
D2
38 52 F Liver Adjacent normal liver tissue of No.26 - * * NAT
D3
39 43 F Liver Cancer adjacent liver tissue of No.27 - * * AT
D4
40 59 M Lung Cancer adjacent lung tissue of No.28 - * * AT
D5
41 70 M Lung Adjacent normal lung tissue of No.29 - * * NAT
D6
42 62 M Lung Adjacent normal lung tissue of No.30 - * * NAT
D7
43 72 F Kindey Adjacent normal kindey tissue of No.31 - * * NAT
D8
44 57 M Kindey Adjacent normal kindey tissue of No.32 - * * NAT
D9
45 45 F Kindey Cancer adjacent kindey tissue of No.33 - * * AT
D10
46 53 F Breast Adjacent normal breast tissue of No.34 (fibrous and adipose tissue) * * * NAT
D11
47 49 F Breast Adjacent normal breast tissue of No.35 * * * NAT
D12
48 29 F Breast Adjacent normal breast tissue of No.36 - * * NAT
E1
49 71 F Cervix Squamous cell carcinoma 2 T1b1N0M0 IB1 Malignant
E2
50 58 F Cervix Squamous cell carcinoma 2 * * Malignant
E3
51 42 F Cervix Squamous cell carcinoma (sparse) 3 * * Malignant
E4
52 58 F Ovary High grade serous carcinoma - T3cN0M0 IIIC Malignant
E5
53 37 F Ovary High grade serous carcinoma - T1aN0M0 IA Malignant
E6
54 67 F Ovary High grade serous carcinoma - T1N0M0 I Malignant
E7
55 79 F Bladder Low grade urothelial carcinoma - T2N0M0 II Malignant
E8
56 54 F Bladder Low grade urothelial carcinoma - T2aN0M0 II Malignant
E9
57 72 F Bladder High grade urothelial carcinoma - T3N0M0 IIIA Malignant
E10
58 39 M Lymph node Diffuse B-cell lymphoma of right armpit - * * Malignant
E11
59 40 M Lymph node Diffuse B-cell lymphoma of left neck - Malignant
E12
60 51 M Lymph node Diffuse B-cell lymphoma of right thigh - * * Malignant
F1
61 45 F Cervix Adjacent normal cervical tissue * * * NAT
F2
62 58 F Cervix Cancer adjacent cervical tissue of No.50 - * * AT
F3
63 27 F Cervix Adjacent normal cervical tissue * * * NAT
F4
64 64 F Ovary Adjacent normal ovary tissue - * * NAT
F5
65 47 F Ovary Adjacent normal ovary tissue - * * NAT
F6
66 29 F Ovary Adjacent normal ovary tissue - * * NAT
F7
67 79 F Bladder Adjacent normal bladder tissue of No.55 - * * NAT
F8
68 54 F Bladder Adjacent normal bladder tissue of No.56 - * * NAT
F9
69 72 F Bladder Cancer adjacent bladder tissue of No.57 - * * AT
F10
70 32 M Lymph node Adjacent normal lymph node tissue - * * NAT
F11
71 35 M Lymph node Adjacent normal lymph node tissue - * * NAT
F12
72 34 M Lymph node Adjacent normal lymph node tissue - * * NAT
G1
73 69 M Skin Squamous cell carcinoma of right shin 2 T2N0M0 II Malignant
G2
74 78 M Skin Squamous cell carcinoma 2 T2N1M0 III Malignant
G3
75 79 M Skin Squamous cell carcinoma of left thigh (sparse) * TisN0M0 0 Malignant
G4
76 58 F Pancreas Adenocarcinoma (sparse) 1 T3N1M0 IIB Malignant
G5
77 55 M Pancreas Adenocarcinoma 2 T3N0M0 IIA Malignant
G6
78 53 M Pancreas Duct adenocarcinoma 2 T3N0M0 IIA Malignant
G7
79 50 M Testis Anaplastic seminoma - T1N0M0 I Malignant
G8
80 55 M Testis Seminoma - T1N0M0 I Malignant
G9
81 55 M Testis Embryonal carcinoma - T1N0M0 I Malignant
G10
82 22 M Testis Embryonal carcinoma - T1N0M0 I Malignant
G11
83 1 M Testis Embryonic rhabdomyosarcoma - T1bN0M0 IIA Malignant
G12
84 18 M Tongue Embryonic rhabdomyosarcoma - T1bN0M0 G3 IIC Malignant
H1
85 62 M Skin Cancer adjacent skin tissue - * * AT
H2
86 78 M Skin Cancer adjacent skin tissue of No.74 * * * AT
H3
87 79 M Skin Cancer adjacent skin tissue of No.75 - * * AT
H4
88 42 M Pancreas Adjacent normal pancreas tissue * * * NAT
H5
89 55 F Pancreas Adjacent normal pancreas tissue - * * NAT
H6
90 51 M Pancreas Adjacent normal pancreas tissue - * * NAT
H7
91 50 M Testis Adjacent normal testis tissue of No.79 - NAT
H8
92 55 M Testis Adjacent normal testis tissue of No.80 - NAT
H9
93 41 M Testis Adjacent normal testis tissue - NAT
H10
94 45 M Testis Adjacent normal testis tissue - NAT
H11
95 4 Mon. F Placenta Placenta tissue - Normal
H12
96 4 Mon. M Placenta Placenta tissue - Normal
_marker_
Find overlapping cases with this tissue array:
  • BCN962c
    File Format: .xlsx
    Release Date: 2025-01-17 15:27:51
    Download
3.668686s